BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12641782)

  • 1. Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumor.
    Hsu PJ; Liu CH; Huang CJ
    J Cutan Pathol; 2003 Mar; 30(3):206-10. PubMed ID: 12641782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands.
    Nishie W; Sawamura D; Mayuzumi M; Takahashi S; Shimizu H
    J Cutan Pathol; 2004 Sep; 31(8):561-4. PubMed ID: 15268713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verrucous carcinoma arising within syringocystadenoma papilliferum.
    Monticciolo NL; Schmidt JD; Morgan MB
    Ann Clin Lab Sci; 2002; 32(4):434-7. PubMed ID: 12458900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoepithelial differentiation in benign sweat gland tumors. Demonstrated by a monoclonal antibody to alpha-smooth muscle actin.
    Eckert F; Betke M; Schmoeckel C; Neuweiler J; Schmid U
    J Cutan Pathol; 1992 Aug; 19(4):294-301. PubMed ID: 1331211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is tubular apocrine adenoma a distinct clinical entity?
    Ishiko A; Shimizu H; Inamoto N; Nakmura K
    Am J Dermatopathol; 1993 Oct; 15(5):482-7. PubMed ID: 8238787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands: report of a case and review of the literature.
    Parks A; Branch KD; Metcalf J; Underwood P; Young J
    Am J Dermatopathol; 2012 Feb; 34(1):104-9. PubMed ID: 22262361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
    Aktepe F; Demir Y; Dilek FH
    Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed syringocystadenoma papilliferum and papillary eccrine adenoma occurring in a scrotal condyloma.
    Coyne JD; Fitzgibbon JF
    J Cutan Pathol; 2000 Apr; 27(4):199-201. PubMed ID: 10774942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tubulo-papillary apocrine adenoma in association with syringocystadenoma papilliferum].
    Ayadi L; Mallouli M; Kallel R; Charfi S; Makni S; Boudawara TS; Gouiaa N
    Ann Pathol; 2016 Oct; 36(5):355-357. PubMed ID: 27693311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringocystadenoma papilliferum associated with apocrine poroma.
    Suzuki T; Ikeda H; Hamasaki Y; Hatamochi A; Yamazaki S
    J Dermatol; 2006 Apr; 33(4):249-51. PubMed ID: 16674787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of Syringocystadenoma Papilliferum with Tubular Papillary Adenoma of the Chest.
    Ito K; Ansai SI; Saeki H
    J Nippon Med Sch; 2017; 84(2):79-82. PubMed ID: 28502963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Syringocystadenoma papilliferum].
    Baino A; Akhdari N; Amal S; Hamdaoui A; Abbad F; Rais H
    Ann Dermatol Venereol; 2015; 142(6-7):460-2. PubMed ID: 25956460
    [No Abstract]   [Full Text] [Related]  

  • 13. Tubulopapillary Cystic Adenoma With Apocrine Differentiation: A Unifying Concept for Syringocystadenoma Papilliferum, Apocrine Gland Cyst, and Tubular Papillary Adenoma.
    Ansai SI; Anan T; Fukumoto T; Saeki H
    Am J Dermatopathol; 2017 Nov; 39(11):829-837. PubMed ID: 28033156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of lysozyme in various benign sweat apparatus tumors.
    Katsumata M; Ezoe K
    J Dermatol; 1990 May; 17(5):307-11. PubMed ID: 2166096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin.
    Liau JY; Tsai JH; Huang WC; Lan J; Hong JB; Yuan CT
    Hum Pathol; 2018 Mar; 73():59-65. PubMed ID: 29241739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
    Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
    An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital papillated apocrine cystadenoma: a mixed form of hidrocystoma, hidradenoma papilliferum, and syringocystadenoma papilliferum.
    Schewach-Millet M; Trau H
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 2):374-6. PubMed ID: 6090513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubular apocrine adenoma with eccrine and apocrine immunophenotypes or papillary tubular adenoma?
    Tellechea O; Reis JP; Marques C; Baptista AP
    Am J Dermatopathol; 1995 Oct; 17(5):499-505. PubMed ID: 8599457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syringocystadenoma papilliferum of the eyelid.
    Perlman JI; Urban RC; Edward DP; Tso MO
    Am J Ophthalmol; 1994 May; 117(5):647-50. PubMed ID: 8172272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex sweat gland hamartoma: A case report.
    Skopec Z; Berrebi KG; Stone M; Liu V
    J Cutan Pathol; 2023 Mar; 50(3):243-246. PubMed ID: 36323653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.